Aureka Biotechnologies Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$100M
- Investors
-
14
Aureka Biotechnologies General Information
Description
Developer of a therapeutic discovery platform intended to digitalize therapeutic design at scale. The company's platform leverages cutting-edge machine learning and artificial intelligence to identify and design potential drug candidates, enabling the pharmaceutical industry to develop novel treatments to reduce cost and time.
Contact Information
Website
www.aurekabio.comCorporate Office
- 23181 Verdugo Drive
- Suite 106
- Laguna Hills, CA 92653
- United States
Corporate Office
- 23181 Verdugo Drive
- Suite 106
- Laguna Hills, CA 92653
- United States
Aureka Biotechnologies Timeline
Aureka Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 11-Aug-2026 | $100M | Completed | Clinical Trials - General | ||
| 3. Early Stage VC (Series A) | 28-Apr-2026 | Completed | Clinical Trials - General | |||
| 2. Seed Round | 25-Jun-2023 | $10M | $10M | Completed | Clinical Trials - General | |
| 1. Accelerator/Incubator | 06-Jun-2023 | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Aureka Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aureka Biotechnologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aureka Biotechnologies Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Granite Asia | Venture Capital | Minority | ||
| Highlight Capital | Venture Capital | Minority | ||
| 5Y Capital | Venture Capital | Minority | ||
| Agentic Ventures | Venture Capital | Minority | ||
| Boyuan Capital | Corporate Venture Capital | Minority |
Aureka Biotechnologies FAQs
-
When was Aureka Biotechnologies founded?
Aureka Biotechnologies was founded in 2023.
-
Where is Aureka Biotechnologies headquartered?
Aureka Biotechnologies is headquartered in Laguna Hills, CA.
-
What is the size of Aureka Biotechnologies?
Aureka Biotechnologies has 38 total employees.
-
What industry is Aureka Biotechnologies in?
Aureka Biotechnologies’s primary industry is Drug Discovery.
-
Is Aureka Biotechnologies a private or public company?
Aureka Biotechnologies is a Private company.
-
What is Aureka Biotechnologies’s current revenue?
The current revenue for Aureka Biotechnologies is .
-
How much funding has Aureka Biotechnologies raised over time?
Aureka Biotechnologies has raised $168M.
-
Who are Aureka Biotechnologies’s investors?
Granite Asia, Highlight Capital, 5Y Capital, Agentic Ventures, and Boyuan Capital are 5 of 14 investors who have invested in Aureka Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
